Revvity to Present at Upcoming Investor Conferences
Business Wire (Tue, 13-Oct 8:00 AM ET)
Bernstein Sticks to Their Hold Rating for Revvity (RVTY)
TipRanks (Mon, 12-Oct 6:36 AM ET)
Business Wire (Tue, 6-Oct 8:00 AM ET)
Revvity to Hold Earnings Call on November 3, 2026
Business Wire (Fri, 2-Oct 8:00 AM ET)
Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
Business Wire (Thu, 24-Sep 8:00 AM ET)
Business Wire (Wed, 9-Sep 6:00 AM ET)
Revvity Announces Financial Results for the Second Quarter of 2026
Business Wire (Tue, 4-Aug 6:00 AM ET)
Revvity Board Declares Quarterly Dividend
Business Wire (Fri, 31-Jul 4:05 PM ET)
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure
Business Wire (Mon, 20-Jul 8:00 AM ET)
Market Chameleon (Tue, 5-May 5:24 AM ET)
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Revvity trades on the NYSE stock market under the symbol RVTY.
As of October 15, 2026, RVTY stock price climbed to $154.71 with 2,190,272 million shares trading.
RVTY has a beta of 1.14, meaning it tends to be more sensitive to market movements. RVTY has a correlation of 0.12 to the broad based SPY ETF.
RVTY has a market cap of $17.26 billion. This is considered a Large Cap stock.
Last quarter Revvity reported $730 million in Revenue and $1.41 earnings per share. This beat revenue expectation by $26 million and exceeded earnings estimates by $.19.
In the last 3 years, RVTY traded as high as $166.25 and as low as $79.50.
The top ETF exchange traded funds that RVTY belongs to (by Net Assets): VTI, VOO, VB, RSP, IVV.
RVTY has outperformed the market in the last year with a return of +70.1%, while the SPY ETF gained +17.7%. In the last 3 month period, RVTY beat the market returning +39.2%, while SPY returned +2.9%. However, in the most recent 2 weeks RVTY has underperformed the stock market by returning +1.2%, while SPY returned +1.2%.
RVTY support price is $148.02 and resistance is $156.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RVTY shares will trade within this expected range on the day.